IKA

Ilika targets Europe’s next phase of solid-state battery development

Ilika is positioned around Europe’s push for next-generation solid-state batteries as manufacturers seek better performance and less dependence on Asian supply chains...

Ilika targets lighter EV battery packs

Ilika’s Goliath solid-state battery technology targets a higher cell-to-pack ratio by combining high-nickel NMC chemistry with a non-flammable solid electrolyte...

Ilika’s Graeme Purdy on Goliath, defence and Brompton progress (LON:IKA)

Ilika CEO Graeme Purdy discusses the completion of the PRIMED programme, improved consistency in Goliath battery performance, growing defence interest and progress with Brompton on e-bike battery applications...

Ilika appoints Robin Anderton-Brown as strategic defence advisor

Former UK Strategic Command Director of Capability Robin Anderton-Brown joins Ilika as a strategic advisor, supporting opportunities for its Goliath solid-state batteries in the defence sector...

Ilika plc: Goliath gains commercial momentum as validation, defence interest and Brompton trials converge (video)

Ilika plc (LON:IKA) CEO Graeme Purdy explains why one of Goliath’s most important advances may not be a headline performance metric at all, but the tighter consistency now being delivered..

Ilika completes PRIMED programme with improved Goliath battery performance

Ilika has completed its £3 million PRIMED programme, reporting improved energy density, charging, power, cycle life and thermal stability for its 10Ah Goliath solid-state battery cells, alongside new commercial opportunities..

Ilika to present UK-developed quasi-solid-state cell technology at Faraday Event

Ilika will present its UK-developed quasi-solid-state cell technology at The Faraday Institution’s Next Frontiers in Energy Storage event on Tuesday 8 September...

Ilika targets MedTech adoption with Stereax solid-state batteries

Ilika is targeting medical device and IoT applications with its Stereax miniature solid-state batteries, supported by a manufacturing and commercialisation agreement with Cirtec Medical...

Ilika confirms AGM date and Annual Report posting

Ilika has given notice of its 2026 Annual General Meeting and said its annual report and AGM notice will be available shortly...

Ilika targets medical device opportunities with Stereax at MedTech Ireland

Ilika’s Stereax technology will be presented at MedTech Ireland 2026 as the company targets further opportunities in active implanted medical devices...

Ilika advances Goliath towards commercial deployment

Ilika is advancing Goliath through testing and manufacturing scale-up while targeting shorter-cycle markets alongside longer-term electric vehicle adoption...

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production...

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes...

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector...

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point...

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in..

Ilika builds commercial momentum across Stereax and Goliath batteries

Ilika Plc reports annual results for the year ended 30 April 2026, highlighting progress on its Stereax medical battery line and Goliath large-format batteries for EV, defence and consumer applications...

Defence demand puts specialist battery technology in focus

Defence applications are increasing the need for specialist batteries that can deliver reliable power in demanding operating conditions...

Battery & Energy Storage Tech Europe 2026 targets the next phase of industrial growth

Battery & Energy Storage Tech Europe 2026 will focus on financing, deployment, manufacturing, recycling and regulation across Europe’s battery market...

Ilika moves Goliath cells into independent commercial testing

Ilika has moved its UK-made Goliath cells into independent testing as it targets commercial opportunities in automotive, defence and e-bike markets...
Search

Funds

IKA

Ilika targets Europe’s next phase of solid-state battery development

Ilika is positioned around Europe’s push for next-generation solid-state batteries as manufacturers seek better performance and less dependence on Asian supply chains...

Ilika targets lighter EV battery packs

Ilika’s Goliath solid-state battery technology targets a higher cell-to-pack ratio by combining high-nickel NMC chemistry with a non-flammable solid electrolyte...

Ilika’s Graeme Purdy on Goliath, defence and Brompton progress (LON:IKA)

Ilika CEO Graeme Purdy discusses the completion of the PRIMED programme, improved consistency in Goliath battery performance, growing defence interest and progress with Brompton on e-bike battery applications...

Ilika appoints Robin Anderton-Brown as strategic defence advisor

Former UK Strategic Command Director of Capability Robin Anderton-Brown joins Ilika as a strategic advisor, supporting opportunities for its Goliath solid-state batteries in the defence sector...

Ilika completes PRIMED programme with improved Goliath battery performance

Ilika has completed its £3 million PRIMED programme, reporting improved energy density, charging, power, cycle life and thermal stability for its 10Ah Goliath solid-state battery cells, alongside new commercial opportunities in defence, e-bikes and other applications...

Ilika to present UK-developed quasi-solid-state cell technology at Faraday Event

Ilika will present its UK-developed quasi-solid-state cell technology at The Faraday Institution’s Next Frontiers in Energy Storage event on Tuesday 8 September...

Ilika targets MedTech adoption with Stereax solid-state batteries

Ilika is targeting medical device and IoT applications with its Stereax miniature solid-state batteries, supported by a manufacturing and commercialisation agreement with Cirtec Medical...

Ilika confirms AGM date and Annual Report posting

Ilika has given notice of its 2026 Annual General Meeting and said its annual report and AGM notice will be available shortly...

Ilika targets medical device opportunities with Stereax at MedTech Ireland

Ilika’s Stereax technology will be presented at MedTech Ireland 2026 as the company targets further opportunities in active implanted medical devices...

Ilika advances Goliath towards commercial deployment

Ilika is advancing Goliath through testing and manufacturing scale-up while targeting shorter-cycle markets alongside longer-term electric vehicle adoption...

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production...

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes...

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector...

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point...

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in defence and sovereign battery supply...

Ilika builds commercial momentum across Stereax and Goliath batteries

Ilika Plc reports annual results for the year ended 30 April 2026, highlighting progress on its Stereax medical battery line and Goliath large-format batteries for EV, defence and consumer applications. The company began Stereax production and deliveries, shipped larger Goliath prototypes, secured further grant funding and raised £5 million post-period to accelerate commercialisation...

Defence demand puts specialist battery technology in focus

Defence applications are increasing the need for specialist batteries that can deliver reliable power in demanding operating conditions...

Battery & Energy Storage Tech Europe 2026 targets the next phase of industrial growth

Battery & Energy Storage Tech Europe 2026 will focus on financing, deployment, manufacturing, recycling and regulation across Europe’s battery market...

Ilika moves Goliath cells into independent commercial testing

Ilika has moved its UK-made Goliath cells into independent testing as it targets commercial opportunities in automotive, defence and e-bike markets...
Search

Funds

IKA

FTSE 100

Funds